SCONE™ delivers proprietary modulated waveforms of varying current to designated areas of the spine in a specific sequence via hydrogel electrodes directly over the skin without causing any pain or discomfort to patients. This proprietary method of reactivating spinal circuits is the key invention and is protected by the SpineX’s patent portfolio. SCONE™ is being developed and tested to enable improvement in lower extremity function, upper extremity function, bladder and bowel function, breathing function.

SCONETM has been recognized by FDA as a Breakthrough Device.

SCONETM is an investigational device and is limited by Federal (USA) law to investigational use only. FDA has not reviewed the safety and effectiveness of SCONE.

Contact Us

Fill in your information to reach out.